A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): an observational cohort study.
Cantaert T, Borand L, Kergoat L, Leng C, Ung S, In S, Peng Y, Phoeun C, Hing C, Taing CN, Saman M, Ong S, Mey C, Choeung R, Ly S, Dussart P, Bourhy H, Tarantola A.
Cantaert T, et al. Among authors: peng y.
Lancet Infect Dis. 2019 Dec;19(12):1355-1362. doi: 10.1016/S1473-3099(19)30311-1. Epub 2019 Sep 27.
Lancet Infect Dis. 2019.
PMID: 31570311